AR219150A1 - Procedimiento para preparar nuevos derivados de aminoazucares - Google Patents
Procedimiento para preparar nuevos derivados de aminoazucaresInfo
- Publication number
- AR219150A1 AR219150A1 AR275445A AR27544579A AR219150A1 AR 219150 A1 AR219150 A1 AR 219150A1 AR 275445 A AR275445 A AR 275445A AR 27544579 A AR27544579 A AR 27544579A AR 219150 A1 AR219150 A1 AR 219150A1
- Authority
- AR
- Argentina
- Prior art keywords
- aminoazucar
- derivatives
- procedure
- preparing new
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB583478 | 1978-02-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR219150A1 true AR219150A1 (es) | 1980-07-31 |
Family
ID=9803510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR275445A AR219150A1 (es) | 1978-02-14 | 1979-02-08 | Procedimiento para preparar nuevos derivados de aminoazucares |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4273765A (zh) |
| EP (1) | EP0003616B1 (zh) |
| JP (1) | JPS54163511A (zh) |
| AR (1) | AR219150A1 (zh) |
| AT (1) | AT367451B (zh) |
| AU (1) | AU527318B2 (zh) |
| CA (1) | CA1121290A (zh) |
| DE (2) | DE2905649A1 (zh) |
| DK (1) | DK149599C (zh) |
| ES (1) | ES477653A1 (zh) |
| FI (1) | FI63062C (zh) |
| FR (1) | FR2416901A1 (zh) |
| GR (1) | GR72817B (zh) |
| HU (1) | HU181442B (zh) |
| IE (1) | IE47916B1 (zh) |
| IL (1) | IL56626A0 (zh) |
| LU (1) | LU80906A1 (zh) |
| MC (1) | MC1253A1 (zh) |
| NL (1) | NL7901182A (zh) |
| NO (1) | NO153011C (zh) |
| NZ (1) | NZ189625A (zh) |
| PH (1) | PH15084A (zh) |
| PT (1) | PT69218A (zh) |
| SE (1) | SE7901276L (zh) |
| YU (1) | YU41437B (zh) |
| ZA (1) | ZA79528B (zh) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0056194B1 (en) * | 1981-01-05 | 1984-09-12 | Takeda Chemical Industries, Ltd. | N-substituted pseudo-aminosugars, their production and use |
| JPS57146713A (en) * | 1981-03-09 | 1982-09-10 | Akira Endo | Hypoglycemic |
| US4595678A (en) * | 1982-03-19 | 1986-06-17 | Takeda Chemical Industries, Ltd. | N-substituted pseudo-aminosugars and pharmaceutical compositions containing same |
| US4678812A (en) * | 1986-05-30 | 1987-07-07 | E. I. Du Pont De Nemours And Company | Trehalose as stabilizer and tableting excipient |
| US4762857A (en) * | 1986-05-30 | 1988-08-09 | E. I. Du Pont De Nemours And Company | Trehalose as stabilizer and tableting excipient |
| US4885361A (en) * | 1987-07-31 | 1989-12-05 | Hoffmann-La Roche Inc. | Sulfated oligosaccharides |
| EP0559795B1 (en) * | 1990-11-30 | 1995-12-27 | Monoclonetics International, Inc. | Methods for the diagnosis of chronic lower back and cervical pain |
| TW381025B (en) * | 1993-08-05 | 2000-02-01 | Hoffmann La Roche | Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor |
| US7022684B2 (en) * | 2000-05-24 | 2006-04-04 | Pfizer Inc. | Treatment of rumen acidosis with α-amylase inhibitors |
| EP1157696B1 (en) * | 2000-05-24 | 2006-10-25 | Pfizer Limited | Treatment of rumen acidosis with alpha-amylase inhibitors |
| CA2546601A1 (en) | 2003-11-19 | 2005-06-09 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
| US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
| US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
| DE602005016009D1 (de) * | 2004-11-23 | 2009-09-24 | Warner Lambert Co | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure-derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| EP2170930B3 (en) | 2007-06-04 | 2013-10-02 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| BRPI0911063A2 (pt) | 2008-04-11 | 2016-11-01 | Astellas Pharma Inc | composto aminoaçúcar e processo para produção do mesmo |
| WO2009149279A2 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
| WO2011145022A1 (en) | 2010-05-21 | 2011-11-24 | Pfizer Inc. | 2-phenyl benzoylamides |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2012120414A2 (en) | 2011-03-04 | 2012-09-13 | Pfizer Inc. | Edn3-like peptides and uses thereof |
| WO2013133685A1 (en) | 2012-03-09 | 2013-09-12 | Biotropics Malaysia Berhad | Extract formulations of rhodamnia cinerea and uses thereof |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| KR101695582B1 (ko) | 2013-04-17 | 2017-01-13 | 화이자 인코포레이티드 | 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체 |
| BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
| KR102431436B1 (ko) | 2014-08-29 | 2022-08-10 | 테스 파마 에스.알.엘. | α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| KR20190065312A (ko) | 2016-10-14 | 2019-06-11 | 테스 파마 에스.알.엘. | 알파-아미노-베타-카복시뮤콘산 세미알데하이드 데카복실라제의 저해제 |
| KR20210111248A (ko) | 2018-11-20 | 2021-09-10 | 테스 파마 에스.알.엘. | α-아미노-β-카르복시뮤콘산 세미알데하이드 데카르복실라제의 저해제 |
| EA202191892A1 (ru) | 2019-01-18 | 2022-02-24 | Астразенека Аб | Ингибиторы pcsk9 и способы их применения |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2064092C2 (de) * | 1970-12-28 | 1983-06-01 | Bayer Ag, 5090 Leverkusen | Inhibitoren für Glykosidhydrolasen aus Actinomyceten |
| DE2347782C3 (de) * | 1973-09-22 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| US4062950A (en) * | 1973-09-22 | 1977-12-13 | Bayer Aktiengesellschaft | Amino sugar derivatives |
| US4065557A (en) * | 1974-03-21 | 1977-12-27 | Bayer Aktiengesellschaft | Amino sugars and their use in improving the meat:fat ratio in animals |
| USRE29903E (en) | 1975-03-19 | 1979-02-06 | American Cyanamid Company | Antibacterial antibiotics AM31α, AM31β and AM31γ |
| DE2614393C3 (de) * | 1976-04-02 | 1980-04-03 | Bayer Ag, 5090 Leverkusen | Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel |
-
1979
- 1979-01-31 CA CA000320579A patent/CA1121290A/en not_active Expired
- 1979-02-07 ZA ZA79528A patent/ZA79528B/xx unknown
- 1979-02-07 AU AU44028/79A patent/AU527318B2/en not_active Ceased
- 1979-02-07 PH PH22174A patent/PH15084A/en unknown
- 1979-02-08 IL IL56626A patent/IL56626A0/xx not_active IP Right Cessation
- 1979-02-08 AR AR275445A patent/AR219150A1/es active
- 1979-02-09 US US06/011,002 patent/US4273765A/en not_active Expired - Lifetime
- 1979-02-12 FR FR7903452A patent/FR2416901A1/fr active Granted
- 1979-02-12 LU LU80906A patent/LU80906A1/de unknown
- 1979-02-12 NZ NZ189625A patent/NZ189625A/xx unknown
- 1979-02-12 HU HU79HO2138A patent/HU181442B/hu not_active IP Right Cessation
- 1979-02-13 PT PT7969218A patent/PT69218A/pt unknown
- 1979-02-13 DK DK61179A patent/DK149599C/da active
- 1979-02-13 NO NO790469A patent/NO153011C/no unknown
- 1979-02-13 AT AT0108879A patent/AT367451B/de not_active IP Right Cessation
- 1979-02-13 SE SE7901276A patent/SE7901276L/ not_active Application Discontinuation
- 1979-02-13 ES ES477653A patent/ES477653A1/es not_active Expired
- 1979-02-13 GR GR58344A patent/GR72817B/el unknown
- 1979-02-13 MC MC791365A patent/MC1253A1/xx unknown
- 1979-02-13 JP JP1443879A patent/JPS54163511A/ja active Granted
- 1979-02-13 IE IE274/79A patent/IE47916B1/en not_active IP Right Cessation
- 1979-02-14 EP EP79100441A patent/EP0003616B1/de not_active Expired
- 1979-02-14 YU YU348/79A patent/YU41437B/xx unknown
- 1979-02-14 FI FI790486A patent/FI63062C/fi not_active IP Right Cessation
- 1979-02-14 NL NL7901182A patent/NL7901182A/xx not_active Application Discontinuation
- 1979-02-14 DE DE19792905649 patent/DE2905649A1/de not_active Withdrawn
- 1979-02-14 DE DE7979100441T patent/DE2962165D1/de not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR219150A1 (es) | Procedimiento para preparar nuevos derivados de aminoazucares | |
| ES497884A0 (es) | Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina | |
| MX5973E (es) | Procedimiento para preparar compuestos cefem | |
| AR225143A1 (es) | Procedimiento para preparar derivados de fenil-metil-hidantoina | |
| MX5880E (es) | Procedimiento para preparar derivados de bencilimidazol | |
| ES490504A0 (es) | Procedimiento para preparar nuevos compuestos de tiadiazoli-lo | |
| ES488593A0 (es) | Procedimiento para preparar derivados de ciclopropano | |
| ES488635A0 (es) | Procedimiento para preparar derivados de pirimidina | |
| ES494119A0 (es) | Procedimiento para preparar derivados de 3-aminoproxiarilo | |
| MX5399E (es) | Procedimiento para preparar derivados de propanona | |
| ES492032A0 (es) | Procedimiento para preparar compuestos de cefem | |
| ES488772A0 (es) | Procedimiento para preparar derivados de pirimidona | |
| AR226694A1 (es) | Procedimiento para obtener nuevos derivados de antraciclina | |
| AR224784A1 (es) | Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina | |
| MX151851A (es) | Procedimiento mejorado para preparar derivados de triacina | |
| MX6291E (es) | Procedimiento para preparar derivados de n-bencilhalogenoacetamida | |
| MX5724E (es) | Procedimiento para preparar metil eteres de cetoximas sustituidas | |
| MX5160E (es) | Procedimiento mejorado para preparar derivados de aminoalcoholes | |
| ES492394A0 (es) | Procedimiento para preparar derivados de pirimidina | |
| MX6971E (es) | Procedimiento para preparar derivados de tetrahidroquinolina | |
| AR226210A1 (es) | Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona | |
| AR223161A1 (es) | Procedimiento para preparar n-etiletilendiamina | |
| ES492692A0 (es) | Procedimiento para preparar derivados de benoimidazol | |
| AR223177A1 (es) | Procedimiento para preparar derivados de indolo-isoquinolina | |
| MX150040A (es) | Procedimiento mejorado para preparar 3-metil-ciclopentadecanona |